版本:
中国

BRIEF-Novartis says analyses reinforce potential of Ultibro Breezhaler for COPD patients

May 23 Novartis Ag

* Novartis' new analyses reinforce the potential of Ultibro Breezhaler for COPD patients historically treated with steroids Source text for Eikon: Further company coverage: (Reporting By Zurich newsroom)

我们的标准: 汤森路透“信任原则

更多 瑞士市场报道

热门文章

编辑推荐

文章推荐